期刊文献+

乌拉地尔和尼卡地平对老年高血压急症的疗效及安全性比较 被引量:45

Efficiency and safety of urapidil and nicardipine in elderly emergency hypertensive patients
下载PDF
导出
摘要 目的探讨乌拉地尔和尼卡地平治疗老年高血压急症的疗效和不良反应。方法老年高血压急症患者39例,随机分为乌拉地尔组22例和尼卡地平组17例,分别给予乌拉地尔和尼卡地平降压,记录2组治疗前及治疗后5、10、15、20、25、30、60min、2h及离院时收缩压、舒张压、平均动脉压(MAP)和心率及不良反应。结果 2组治疗前后收缩压、舒张压、MAP和心率比较,差异无统计学意义(P>0.05);2组治疗前后不同时间点收缩压与治疗前收缩压差值比较,差异无统计学意义(P>0.05);2组治疗后2h舒张压和MAP与治疗前差值比较,差异有统计学意义(P<0.05,P<0.01),乌拉地尔组下降更加明显(P<0.01)。结论乌拉地尔和尼卡地平对老年高血压急症症状的缓解及对收缩压降压效果相当;乌拉地尔起效更快且有进一步使舒张压和MAP降低的趋势;2组均可使心率下降,尼卡地平治疗早期患者心率可一过性上升,但并不显著增加心率;2种药物安全性均较好。 Objective To study the efficiency and adverse reactions of urapidil and nicardipine in elderly emergency hypertensive patients. Methods Thirty-nine elderly emergency hypertensive patients were randomly divided into urapidil treatment group (group A,n= 22) and nicardipine treatment group (group B,n=17). Their SBP,DBP,MAP and adverse reactions were recorded be fore and 5,10,15,20,25,30,60 min,2 h after treatment. Results No significant difference was found in SBP,DBP,MAP and HR between the two groups (P〉0.05) and in SBP between the two groups before and after treatment at different time points (P〉0.05). The DBP and MAP were significantly lower in group A than in group B 2 h after treatment (P〈0.05 ,P〈0.01 ). Con- clusion The efficiency of urapidil and nicardipine is similar in alleviating the symptoms and re- ducing the SBP in elderly emergency hypertensive patients. Urapidil can further reduce the DBP and MAP due to its rapider efficiency. Urapidil and nicardipine can decrease the HR. However, nicardipine increases the transient HR but not significantly increases the HR. The safety of urapi dil and nicardipine is good in elderly emergency hypertensive patients.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2014年第4期370-373,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 高血压 急症 肾上腺素能Α拮抗剂 治疗结果 尼卡地平 hypertension emergencies adrenergic alpha-antagonists treatment outcome nicardip ine
  • 相关文献

参考文献8

  • 1Johnson W, Nguyen ML, Patel R. Hypertension crisis in the emergency department. Cardiol Clin, 2012,30 : 533-543. 被引量:1
  • 2杨泽民,李宁榕,朱小玲.开搏通舌下含服与乌拉地尔静脉用药治疗高血压急症对比分析[J].中国危重病急救医学,2004,16(3):164-164. 被引量:13
  • 3Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute Joint National Committee on Preven- tion, Detection, Evaluation, and Treatment of High Blood Pres- sure National High Blood Pressure Education Program Coor- dinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treat- ment of High Blood Pressure: the JNC 7 report. JAMA, 2003, 289,2560. 被引量:1
  • 4王晓明,丁铭格,张航向.老年高血压诊疗的思考及治疗对策[J].中华老年心脑血管病杂志,2013,15(3):225-227. 被引量:22
  • 5吴辉,常静,丁家望,杨俊,程海旭.从不同国际高血压治疗指南看老年及老老年高血压的治疗策略[J].中华老年心脑血管病杂志,2013,15(3):334-336. 被引量:37
  • 6Cannon CM, Levy P, Baumann BM, et al. Intravenous nicardip ine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department :a subgroup analysis of the CLUE trial. BMJ Open, 2013,3:e002338. 被引量:1
  • 7Fugit MD, Rubal BJ, Donovan DJ. Effects of intracoronary nicardipine,diltiazem and verapamil on coronary blood flow. J Invasive Cardiol, 2000,12: 80-85. 被引量:1
  • 8盐酸乌拉地尔注射液临床应用专家共识组.盐酸乌拉地尔注射液临床应用专家共识.中华急诊医学杂志,2013,22:960-965. 被引量:2

二级参考文献24

  • 1吴端源,施群力,吴奕真,吴顺荣.卡托普利及地尔硫含服治疗高血压急症的疗效观察[J].中国危重病急救医学,1996,8(6):360-361. 被引量:2
  • 2. 被引量:1
  • 3. 被引量:1
  • 4. 被引量:1
  • 5Aronow WS,Fleg JL,Pepine CJ,et al. ACCF/AHA 2011 ex . pert consensus document on hypertension in the elderly:a re- port of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, A merican Geriatrics Society, American Society for Preventive Cardiology,American Society of Hypertension, American So ciety of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens, 2011,5:259 352. 被引量:1
  • 6Wang JG, Staessen JA, Gong L, et al. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (SysbChina) Collaborative Group. Arch Intern Meal, 2000,160 : 211-220. 被引量:1
  • 7Beckett NS,Peters R,Fletcher AE,et al. Treatment of hyper- tension in patients 80 years of age or older. N Engl J Med, 2008,358 : 1887-1898. 被引量:1
  • 8JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res, 2008,31 : 2115-2127. 被引量:1
  • 9Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens, 2010,28 : 1366- 1372. 被引量:1
  • 10Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hy- pertension,2010,56 : 196- 202. 被引量:1

共引文献64

同被引文献262

引证文献45

二级引证文献192

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部